of thyroid function is well established, and in most hospitals it is in routine use. But it does not offer us a universally valid test free of any limitations, and it is useful to supplement it with other tests of thyroid function.20 For the most part, both the special advantages and limitations of radioiodine tests differ from those of the alternative tests, to which they are therefore complementary; where radioiodine is inapplicable or its results unexpected from the clinical picture, recourse to another test will usually clarify the problem. However, it must be admitted that the reliable detection of partial thyroid failure by any test remains difficult. As a consequence opinions differ on the syndrome, incidence and treatment of mild hypothyroidism. For example, a recent controversy about' metabolic insufficiency,' which was said to respond to triiodothyronine but not to thyroxine treatment, has only been settled by ' double-blind' testing of the response to treatment, e.g. Sikkema .YO Some may think that the technically delicate and costly protein-bound iodine test (P.B. 1271) has filled this loophole.
However, Lowrey and Starr,38 who for long have been the protagonists of this test and so perform it more accurately than most, found an incidence of 4-9% of subnormal values amongst various sample groups of the normal working population. These people had no symptoms, so that it is likely that these findings reflect the error of the test rather than of the frequency of a real endocrine abnormality. It must be admitted that radioiodine offers no help here. This is even more a blind spot for radioiodine than for the other tests, but it is practically its only one, provided the ingestion of drugs which might affect thyroid function can be excluded. Radioiodine tests can be used to demonstrate or exclude either complete and near complete failure or any increased activity of the thyroid; and for these purposes their routine methods surpass any other test of thyroid function in efficiency, i.e. in simplicity, sensitivity and accuracy. They can also be used to define more precisely the nature of the disorder in certain thyroid diseases. However Within the thyroid gland (Fig. i) the iodine may be considered as passing through three main pools. From the body's more dilute iodide pool it is first concentrated into (i) the thyroid's iodide pool; thence it becomes organically bound into thyroglobulin, initially by binding to tyrosine and so entering into the hormone's precursor, or (2) iodotyrosine pool (of both mono-and di-iodotyrosine); finally after full synthesis into the stored hormone it enters (3) the thyronine pool (of thyroxine and triiodothyronine); from the last, after hydrolysis of the thyroglobulin, it is eventually secreted into the blood stream (mostly as thyroxine but with 5-io% triiodothyronine).
As thyroglobulin is hydrolysed to release the hormone or the thyronines, the simultaneously Note increased rate of transfer at all steps in thyrotoxicosis, but only at the step from iodide to tyrosines in the avid non-toxic goitre.
released iodotyrosines are deiodinated by the gland's deiodinase to iodide which then re-enters the cycle of iodide synthesis in -the thyroid gland.
Hence a counter over the thyroid gland will reflect initially a double process, both the concentrating into the thyroid's iodide pool and the simultaneous organic binding. Within the first hour full mixing of the 'RI label has usually occurred between the body's and the thyroid's iodide pools; and thereafter, with this mixing completed and maintained, the counter really reflects the rate at which organic fixation of iodine is proceeding in the thyroid. Thus most measurements of thyroid uptake, especially the late ones at 24 or 48 hours, are mainly indices of the rate of iodine fixation or organic binding by the thyroid; this rate is, of course, dependent on the concentration of iodide within the gland, so that it may be altered by abnormalities in the concentrating mechanism.
The above considerations explain how a few of the hyperplastic non-toxic goitres may have an avid thyroid uptake, although secreting merely a normal amount of thyroid hormone. For, as indicated in Fig. i , the thyroid gland also incorporates a recycling mechanism, whereby any iodotyrosines freed by the proteolysis which releases the hormone, are deiodinated so that their iodine is released and again enters the first step of organic binding of iodine. Thus if the transfer of iodine from iodotyrosine to thyronine is impaired, this recycling will take a larger proportion of the labelled iodine than does thyronine synthesis; and so the thyroid uptake may be high without any increased rate of formation or of release of thyronine, i.e. without hyperthyroidism. (Fig. 2) . This useful test (best done at 48 hours) unfortunately is not reliable for revealing hypothyroidism because of the extremely low values occasionally found in normal subjects. Furthermore, high ones are found in partial thyroid failure associated with a small thyroid hormone store, e.g. in the earlier stages of lymphadenoid goitre (see Fig. 2 ). However, these apparently ' falsepositives ' are usually revealed as such in untreated subjects by the normal or low associated 48-hour neck uptake, and so these two measurements should be made together. Similar findings due to a small thyroid store may also be encountered after a recent thyroidectomyl' or after radioiodine treatment; here the uptake may also be high. However, the values are usually normal in the'3' I-avid non-toxic goitres (see Fig. 2 ) and always high in hyperthyroidism.
The result of this measurement is best expressed as the concentration of P.B. 13'I per litre of plasma.30, 66 Most of the radioiodine in plasma at 48 hours or later is hormonal so that a useful index, almost as good as any other P.B. l''I index in the absence of renal failure, is obtained merely from the total 48-hour plasma 1311. Sometimes various special ratios are used instead, but the above simpler procedures have advantages over all of these. ' The normal uptake and discharge have been shown to vary with age, as does the basal metabolic rate,41 59 though clinical standards may not need such a fine correction. An adaptation by the thyroid to decreased tissue utilization has been shown as the probable basis of this change. 70 With hyperthyroidism a normal or low result in both uptake and plasma tests is extremely rare and usually excludes the diagnosis, provided there has been no previous abnormal intake of iodine, though very occasionally this may be found with multinodular goitres.39 A high uptake will be found in a small proportion of cases of non-toxic goitre (those hyperplastic and enlarging), as well as in conditions of iodine deficiency such as occurs after the administration of antithyroid drugs, though here the P.B. 1311 is generally normal (though not with extreme iodine deficiency after antithyroid drugs). On the other hand, as already mentioned, high P.B. 131I values may be found when the thyroid store of hormone is reduced after thyroidectomy or after radioiodine treatment and also with lymphadenoid goitre.
A high uptake of 1311 may be found in association with clinical hypothyroidism in lymphadenoid goitre, after antithyroid drugs or in congenital goitres with defective hormone synthesis. Com-plete thyroid failure can be shown with 1311, but, as already noted, the possibility of depressed uptake due to drugs must always be remembered and partial thyroid failure may not show any abnormal result. Subacute thyroiditis is also characterized by absent thyroid uptake but will show clinical evidence of normal or increased thyroid secretion. In clinical hypopituitarism short of complete thyroid failure there may be a normal thyroid uptake of radioiodine, albeit associated with an excessively low P.B. 1311 value.19 On the other hand, radioiodine has proved extremely valuable for testing hypophysectomized subjects for the completeness or at least adequacy of this operation-complete hypophysectomy always showing a very reduced uptake; a clinically satisfactory operation for secondary breast carcinoma should achieve this test standard. 32 There have been several studies of the lymphadenoid goitre's handling of 311I. The uptake may be of any type but there is always a rapid discharge, which is characteristically accelerated when perchlorate is given at one hour. The gland does not respond to T.S.H., suggesting that it is already under maximal stimulation.'2 43 Owens and McConahey45 demonstrated an unusual iodinated protein in the serum of some patients. These 1311 tests in this condition indicate both defective storage and incomplete synthesis of the hormone.
To assess a previous diagnosis of thyroid failure in a patient already taking thyroid, T.S.H. may be given 24 hours before a radioiodine test after which a defective uptake implies some thyroid failure. Einhorn and Larsson'3 have given details of the timing of the different human responses to injected T.S.H. and of the effective dose.
Recent Developments in Radioiodine Tests
Red cell uptake of triiodothyronine. For this test a sample of the patient's red cells is removed and the rate of entry of radioactive triiodothyronine into them is measured in vitro. Studies using this test on a large number of patients have shown that it separates without overlap people with high, normal, and low thyroid function.27 However, abnormal results are also found due to abnormal levels of thyroxine-binding protein (v. infra), and so occur in pregnancy, after oestrogen, in nephrosis and in liver disease, as well as for unexplained reasons in pulmonary insufficiency, and after anticoagulants. A normal result was found with iodide myxoedema. Possibly analogously, it may be noted that red blood cells labelled with 32p lose this radioactive label more rapidly in thyrotoxicosis, and less rapidly than rnormal in myxoedematous subjects.14 67 Two different types of iodide response tests can apparently distinguish thyrotoxicosis from other goitres avid for 131I. In the first, the iodide repletion test, retesting with 1311 at four weeks after two weeks of daily doses of io mg. potassium iodide, reveals the thyrotoxic glands still avid for 1311, but the others showing a normal response. In the second test a smaller dose of iodide (1-2 mg.) is added to a second dose of "3'I given 24 hours after a standard test; only in thyrotoxic glands is this found to depress both the uptake and the discharge of "3'I, thus showing that the thyrotoxic gland is specially susceptible to this acute iodide inhibition.
The thyroid hormone (usually triiodothyrone) suppression test continues to be a useful method for making the same distinction as these two iodide tests. Administration for seven days of about the normal requirements for thyroid hormones or 6o ,ug. of triiodothyronine/day, or preferably of I20 ,ug./day, will suppress the normal uptake of radioiodine and also the thyroid avidity found in hyperplastic non-toxic goitres or in iodine deficiency, but vill not suppress the avid uptake of thyrotoxicosis nor the uptake of some cases of nodular goitre.23 67 The Thyroxine-binding Protein (TBP) As is now emerging for other hormones, most of the thyroid hormone circulates bound to a specific protein (TBP), which has a high affinity for thyroxine but a lesser affinity for its analogues.50' 56 Addition of thyroxine to serum will eventually saturate the protein, after which the excess moves on to a looser binding to the albumin. The concentration of TBP in the plasma may be measured by observing the electrophoretic distribution in the plasma of added "RI-thyroxine, and also the change in this distribution which follows a further addition of an exact amount of unlabelled thyroxine, from which the level of free thyroxine can also be deduced.56 It is the concentration of free thyroxine which probably determines the hormonal drive to the tissues. The concentration of circulating TBP changes little in thyroid disease, but it is strikingly raised in pregnancy, probably due to the effect of the raised oestrogen levels,55 and lowered in nephrosis, probably due to its loss into the urine.22
